Brain white-matter hyperintensities and treatment outcome in major depressive disorder

Br J Psychiatry. 2006 Feb:188:180-5. doi: 10.1192/bjp.188.2.180.

Abstract

Background: An increased incidence of brain white-matter hyperintensities has been described in major depressive disorder, butthe impact of such hyperintensities on treatment outcome is still controversial.

Aims: To investigate the relationship of brain white-matter hyperintensities with cardiovascular risk factors and with treatment outcome in younger people with major depressive disorder.

Method: We assessed brain white-matter hyperintensities and cardiovascular risk factors in 84 people with major depressive disorder prior to initiating antidepressant treatment. We also assessed hyperintensities in 35 matched controls.

Results: We found no significant difference in the prevalence of white-matter hyperintensities between the depression and the control groups. Left-hemisphere subcortical hyperintensities correlated with lower rates of treatment response. We found no correlation between global hyperintensity measures and clinical outcome. Brain white-matter hyperintensities correlated with hypertension and age and withtotal cardiovascular risk score.

Conclusions: Subcortical white-matter hyperintensities in the left hemisphere (but notin other brain areas) maybe associated with poor response to antidepressant treatment in major depression.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Age Factors
  • Aged
  • Antidepressive Agents / therapeutic use
  • Brain / pathology*
  • Cardiovascular Diseases / etiology
  • Cardiovascular Diseases / pathology
  • Depressive Disorder, Major / complications
  • Depressive Disorder, Major / drug therapy
  • Depressive Disorder, Major / pathology*
  • Female
  • Humans
  • Hypertension / etiology
  • Hypertension / pathology
  • Magnetic Resonance Imaging / methods
  • Male
  • Middle Aged
  • Risk Factors
  • Severity of Illness Index
  • Treatment Outcome

Substances

  • Antidepressive Agents